Vincent Piguet - Selected Publications#
Pierre-Gregoire Coulon, Clemence Richetta, Angeline Rouers, Fabien P. Blanchet, Alejandra Urrutia, Mathilde Guerbois, Vincent Piguet, Ioannis Theodorou, Anne Bet, Olivier Schwartz, Frederic Tangy,Stephanie Graff-Dubois, Sylvain Cardinaud and Arnaud Moris. HIV-Infected Dendritic Cells Present Endogenous MHC Class II–Restricted Antigens to HIV-Specific CD4+ T Cells. J Immunol. 2016 Jul 15;197(2):517-32. doi: 10.4049/jimmunol.1600286.
Magdalena A Czubala, Matthew O Ivory, J Paul Mitchell, Zahra Ahmed, Katja Finsterbusch1, Richard O S Karoo, Sion A Coulman, Christopher Gateley, James C Birchall, Fabien P Blanchet, Vincent Piguet. TGF-β Induces a SAMHD1-independent Post-Entry Restriction to HIV-1 Infection of Immature Langerhans Cells. J Invest Dermatol. 2016 Jun 29. pii: S0022-202X(16)32080-2. doi: 10.1016/j.jid.2016.05.123. (IF: 7.2)
Ali FM, Cueva AC, Vyas J, Atwan AA, Salek MS, Finlay AY, Piguet V. A systematic review of the use of quality of life instruments in randomised controlled trials of psoriasis. Br J Dermatol, Br J Dermatol. 2016 Jun 7. doi: 10.1111/bjd.1478
Caucheteux SM, Mitchell JP, Ivory MO, Hirosue S, Hakobyan S, Dolton G, Ladell K, Miners K, Price DA, Kan-Mitchell J, Sewell AK, Nestle F, Moris A, Karoo RO, Birchall JC, Swartz MA, Hubbel JA, Blanchet FP, Piguet V. A Polypropylene sulfide nanoparticle p24 vaccine promotes dendritic cell-mediated specific immune responses against HIV-1. J Invest Dermatol. 2016 Feb 16. pii: S0022-202X(16)00482-6. doi: 10.1016/j.jid.2016.01.033. (IF: 7.2)
Chauhan S*, Ahmed Z*, Bradfute SB, Arko-Mensah J, Mandell MA, Won Choi S, Kimura T, Blanchet F, Waller A, Mudd MH, Jiang S, Sklar L, Timmins GS, Maphis N, Bhaskar K, Piguet V, Deretic V. * Co-first author from my laboratory. Pharmaceutical screen identifies novel target processes for activation of autophagy with a broad translational potential. Nature Commun. 2015 Oct 27;6:8620. (IF: 11.5)
Olsen JR, Gallacher J, Finlay AY, Piguet V, Francis NA. Time to resolution and effect on quality of life of molluscum contagiosum in children in the UK: a prospective community cohort study. Lancet Infect Dis. 2015 Feb;15(2):190-5. doi: 10.1016/S1473-3099(14)71053-9 (IF:19.4)
Blanchet FP, Moris A, Nikolic DS, Lehmann M, Cardinaud S, Stalder R, Garcia E, Dinkins C, Leuba F, Wu L, Schwartz O, Deretic V, Piguet V. Human immunodeficiency virus-1 inhibition of immunoamphisomes in dendritic cells impairs early innate and adaptive immune responses. Immunity. 2010; 32(5): 654-69. (IF: 20.6)
de Witte L, Nabatov A, Pion M, Fluitsma D, de Jong MA, de Gruijl T, Piguet V, van Kooyk Y, Geijtenbeek TB. Langerin is a natural barrier to HIV-1 transmission by Langerhans cells. Nat Med. 2007; 13(3): 367-71 (IF: 26.4)
Pion M, Granelli-Piperno A, Mangeat B, Stalder R, Correa R, Steinman RM, Piguet V. APOBEC3G/3F mediates intrinsic resistance of monocyte-derived dendritic cells to HIV-1 infection. J Exp Med. 2006; 203(13): 2887-93 (IF: 15.6)
Piguet V, Gu F, Foti M, Demaurex N, Gruenberg J, Carpentier JL, Trono D. Nef-induced CD4 degradation: a diacidic-based motif in Nef functions as a lysosomal targeting signal through the binding of beta-COP in endosomes. Cell. 1999; 97(1): 63-73 (IF: 36.4)
